Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05809245 · ClinicalTrials.gov registry record · NA
Corneal Neurotization as a Treatment for Neurotrophic Keratopathy
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT05809245: Clinical Trial NA study, sponsored by Stanford University.
NCT05809245 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05809245, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy of sural nerve transfer and cadaveric nerve graft to re-establish corneal sensation in patients with neurotrophic keratopathy.
Primary Outcome
Corneal sensation will be measured via Cochet Bonnet esthesiometry
Interventions
- PROCEDURE Corneal neurotization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-03-15 |
| Est. Completion | 2020-02-12 |
| Phase | NA |
Why NCT05809245 stopped before completion
NCT05809245 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Corneal neurotization is the first listed.
NCT05809245 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05809245 about?
NCT05809245 is a clinical study titled "Corneal Neurotization as a Treatment for Neurotrophic Keratopathy". The purpose of this study is to assess the efficacy of sural nerve transfer and cadaveric nerve graft to re-establish corneal sensation in patients with neurotrophic keratopathy.
What is the current status of trial NCT05809245?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2018-03-15. Estimated completion is 2020-02-12.
What interventions are being tested in trial NCT05809245?
The interventions under investigation include: Corneal neurotization (PROCEDURE).
Who is sponsoring clinical trial NCT05809245?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05809245's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI